February 11th 2025
In an interview, Debra Patt, MD, PhD, MBA, FASCO, discusses the priorities of the Community Oncology Alliance as she starts her term as president.
Cost-Effectiveness of Medicare Drug Plans in Schizophrenia and Bipolar Disorder
In Medicare Part D, generic drug coverage was cost saving compared with no coverage in bipolar disorder and schizophrenia while improving health outcomes.
Read More